In an effort to revolutionize treatment for spinal cord injuries, Onward Medical has introduced a new non-invasive spinal stimulation device that promises significant improvements in nerve activity and potential growth. In a recent study focusing on patients with quadriplegia, the new ARC-EX device demonstrated promising results.
Within the medical community, the ARC-EX is gaining attention for its ability to deliver electrical stimulation at levels five times higher than previous devices without causing harm to the patients. This innovation could lead to substantial improvements in motor function and rehabilitation outcomes for those suffering from severe spinal injuries.
The hopeful impact of this technology was exemplified by Melanie Reid, a patient left paralyzed from the shoulders down following a horse-riding accident in 2010. Reid’s involvement in the medical trial for the ARC-EX highlighted not only the capability of the device to offer incremental movements but brought to light the life-changing potential of such advancements.
Reid’s experience underscored the importance of hand functionality for individuals with tetraplegia or quadriplegia, emphasizing the device’s potential to significantly enhance patients’ daily lives. The ARC-EX applies non-invasive electrodes near the injury site to stimulate nerve growth during therapy sessions. Its effectiveness was showcased in a study published in Nature Medicine, capturing the hopes of many as an advancement in spinal cord injury treatment.
Source: IEEE Spectrum